tiprankstipranks
Avingtrans PLC (GB:AVG)
LSE:AVG
Want to see GB:AVG full AI Analyst Report?

Avingtrans (AVG) AI Stock Analysis

13 Followers

Top Page

GB:AVG

Avingtrans

(LSE:AVG)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
694.00 p
▲(44.58% Upside)
Action:Downgraded
Date:05/09/26
The score is primarily supported by solid financial performance (growth, improving profitability, low leverage, and stronger free cash flow). This is tempered by technical indicators signaling overbought conditions despite a clear uptrend, while valuation is reasonable but not strongly supported by yield.
Positive Factors
Conservative balance sheet / low leverage
Avingtrans's low debt-to-equity (0.23) and stable equity ratio provide durable financial flexibility. This reduces refinancing risk, supports bidding on long lead-time energy projects, enables capital expenditure and selective M&A, and cushions earnings through cyclical downturns.
Negative Factors
Moderate operating cash conversion
An OCF-to-net-income ratio of 0.21 suggests earnings convert to cash only moderately, possibly due to receivables, inventory or upfront project costs. Over time this constrains organic funding for capex, amplifies working-capital needs and raises vulnerability to project delays.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet / low leverage
Avingtrans's low debt-to-equity (0.23) and stable equity ratio provide durable financial flexibility. This reduces refinancing risk, supports bidding on long lead-time energy projects, enables capital expenditure and selective M&A, and cushions earnings through cyclical downturns.
Read all positive factors

Avingtrans (AVG) vs. iShares MSCI United Kingdom ETF (EWC)

Avingtrans Business Overview & Revenue Model

Company Description
Avingtrans plc manufactures and sells engineered components, systems, and services to the energy, medical, and infrastructure industries worldwide. It operates in three segments: Energy-EPM, Energy-PSRE, and Medical-MII. The company designs, manuf...
How the Company Makes Money
Avingtrans makes money by selling engineered products and associated services across its operating segments. In Energy, revenue is generated from (1) manufacture and sale of specialised equipment used in nuclear and other energy applications (e.g....

Avingtrans Financial Statement Overview

Summary
Financial statements indicate solid performance: revenue growth of 3.96%, healthy gross margin (30.28%) with improving net margin (4.19%), and positive EBIT/EBITDA margin trends. The balance sheet is conservatively financed (debt-to-equity 0.23) with improved ROE (5.80%). Cash flow is improving (free cash flow growth 61.75%) but operating cash flow to net income is only moderate (0.21), limiting the score.
Income Statement
75
Positive
Balance Sheet
70
Positive
Cash Flow
65
Positive
BreakdownTTMMay 2024May 2023May 2022May 2021May 2020
Income Statement
Total Revenue155.49M156.41M136.62M116.44M99.08M98.52M
Gross Profit48.50M47.36M44.04M36.86M32.59M28.38M
EBITDA16.70M15.75M12.54M13.20M12.02M11.03M
Net Income7.06M6.56M3.66M5.19M6.48M3.99M
Balance Sheet
Total Assets196.40M192.76M186.34M155.41M154.69M142.61M
Cash, Cash Equivalents and Short-Term Investments5.62M8.56M12.12M17.72M24.29M30.08M
Total Debt27.28M25.47M23.96M8.58M10.96M9.80M
Total Liabilities76.54M77.53M73.33M46.96M48.88M43.65M
Stockholders Equity117.28M113.14M110.44M106.04M103.82M97.30M
Cash Flow
Free Cash Flow11.11M8.80M-11.06M985.00K-1.10M4.03M
Operating Cash Flow14.29M11.61M1.33M9.68M3.88M6.45M
Investing Cash Flow-14.67M-14.29M-13.58M-12.52M-9.35M24.56M
Financing Cash Flow-4.05M-436.00K6.78M-3.40M-371.00K-5.85M

Avingtrans Technical Analysis

Technical Analysis Sentiment
Positive
Last Price480.00
Price Trends
50DMA
586.80
Positive
100DMA
570.20
Positive
200DMA
522.37
Positive
Market Momentum
MACD
20.52
Negative
RSI
75.39
Negative
STOCH
58.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:AVG, the sentiment is Positive. The current price of 480 is below the 20-day moving average (MA) of 634.80, below the 50-day MA of 586.80, and below the 200-day MA of 522.37, indicating a bullish trend. The MACD of 20.52 indicates Negative momentum. The RSI at 75.39 is Negative, neither overbought nor oversold. The STOCH value of 58.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:AVG.

Avingtrans Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
£221.91M10.696.13%1.02%3.36%63.32%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
63
Neutral
£116.95M7.633.83%6.69%-13.30%-60.03%
62
Neutral
£1.19B11.028.58%3.30%-3.96%192.10%
62
Neutral
£603.97M24.776.66%4.87%-9.46%-57.37%
51
Neutral
£1.04B-8.61-14.17%23.20%18.73%
42
Neutral
£77.44M17.65-12.67%42.24%-432.88%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:AVG
Avingtrans
660.00
279.11
73.28%
GB:BOY
Bodycote
697.50
179.70
34.71%
GB:CGS
Castings
269.00
22.92
9.31%
GB:ITM
ITM Power
150.90
103.70
219.70%
GB:MPAC
Mpac Group PLC
257.50
-187.50
-42.13%
GB:MGAM
Morgan Advanced Materials
218.50
17.99
8.97%

Avingtrans Corporate Events

Business Operations and StrategyProduct-Related AnnouncementsRegulatory Filings and Compliance
Avingtrans’ Adaptix Wins CE Mark for Ortho350 3D Orthopaedic Imaging System
Positive
May 12, 2026
Avingtrans’ medical imaging subsidiary Adaptix has secured CE certification for its Ortho350 orthopaedic 3D imaging system, a compact, mobile Digital Tomosynthesis platform designed for low-dose, high-resolution extremity scans at the point ...
Regulatory Filings and Compliance
Avingtrans Executives Exercise Options as Share Capital Rises
Positive
Apr 30, 2026
Avingtrans has announced the exercise of 352,750 share options by senior executives, including CEO Steve McQuillan, CFO Stephen King and COO Austen Adams, along with certain other participants. Following these exercises and the corresponding issue...
Business Operations and Strategy
Avingtrans Wins Over £10m in Nuclear Orders as SMR and Data Centre Demand Rise
Positive
Apr 16, 2026
Avingtrans’ Advanced Engineering Systems division is seeing strong growth prospects in global nuclear markets, supported by more than £10m of nuclear-related orders since the start of the year. These include a £3m contract for a re...
Business Operations and StrategyProduct-Related Announcements
Avingtrans’ Scientific Magnetics Marks 20th Quantum Magnet Amid UK Push into Quantum Computing
Positive
Mar 26, 2026
Avingtrans’ Oxfordshire-based subsidiary Scientific Magnetics has shipped its 20th superconducting magnet for quantum computing, underscoring the group’s push into high-value, precision technologies that support emerging computing and ...
Business Operations and StrategyDividendsFinancial Disclosures
Avingtrans Lifts Profit and Dividend as Nuclear and Imaging Units Gain Momentum
Positive
Feb 25, 2026
Avingtrans reported flat first-half revenue of £78.1m but improved profitability, with gross margin rising to 31.7%, adjusted EBITDA up 10.4% to £9.6m and adjusted profit before tax up 27.1% to £5.7m. Cash generation strengthened, n...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 09, 2026